Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study

✍ Scribed by E. Calvo; B. Escudier; R.J. Motzer; S. Oudard; T.E. Hutson; C. Porta; S. Bracarda; V. Grünwald; J.A. Thompson; A. Ravaud; D. Kim; A. Panneerselvam; O. Anak; R.A. Figlin

• Book ID: 116430951
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 262 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2011.11.027